Spinal Cord Stimulation Patent Is Obvious, Petitioner Tells Board

(September 11, 2020, 10:02 AM EDT) -- ALEXANDRIA, Va. — In a Sept. 8 petition for inter partes review (IPR), a medical device company and its subsidiary maintain that a method of identifying implanted leads and transmitting electrical pulses through electrodes to stimulate targeted tissue within the spinal cord is unpatentable (Boston Scientific Corporation, et al. v. Nevro Corporation, No. IPR2020-01562, PTAB)....

Attached Documents

Related Sections